Market revenue in 2023 | USD 141.9 million |
Market revenue in 2030 | USD 247.8 million |
Growth rate | 8.3% (CAGR from 2023 to 2030) |
Largest segment | Treatment products |
Fastest growing segment | Diagnostic Products |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Diagnostic Products, Treatment Products |
Key market players worldwide | Merck & Co Inc, Boehringer Ingelheim, Virbac SA, Elanco Animal Health Inc, CEVA Inc, Zoetis Inc Class A, The Hartz Mountain Corporation, Promika, Sergeant's Pet Care Products |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to flea, tick, and heartworm products market will help companies and investors design strategic landscapes.
Treatment products was the largest segment with a revenue share of 75.48% in 2023. Horizon Databook has segmented the Australia flea, tick, and heartworm products market based on diagnostic products, treatment products covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia flea, tick, and heartworm products market , including forecasts for subscribers. This country databook contains high-level insights into Australia flea, tick, and heartworm products market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account